Theranostic nanomedicine for cancer detection and treatment

Journal of Food and Drug Analysis

Volumn 22, Issue 1, 2014, Pages 3-17

  Fan, Zhen ^a   Fu, Peter P ^b   Yu, Hongtao ^a   Ray, Paresh C ^a  

^a JACKSON STATE UNIVERSITY   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Circulating tumor cell diagnosis; Combined therapy; Photothermal therapy; Selective cancer treatment; Theranostic nanomedicine

Indexed keywords

ANTINEOPLASTIC AGENT; GOLD NANOPARTICLE; MAGNETIC NANOPARTICLE; NANOMATERIAL; NANOROD; PHOTOSENSITIZING AGENT;

CANCER DIAGNOSIS; CANCER THERAPY; CELL SEPARATION; CIRCULATING TUMOR CELL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENCAPSULATION; HUMAN; MOLECULAR IMAGING; NANOMEDICINE; NONHUMAN; PHOTODYNAMIC THERAPY; REVIEW; THERANOSTIC NANOMEDICINE; ANIMAL; MOLECULARLY TARGETED THERAPY; MULTIMODALITY CANCER THERAPY; NANOTECHNOLOGY; NEOPLASMS; PROCEDURES; TUMOR EMBOLISM;

ANIMALS; COMBINED MODALITY THERAPY; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; HUMANS; MOLECULAR TARGETED THERAPY; NANOMEDICINE; NANOTECHNOLOGY; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING;

EID: 84901620567     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfda.2014.01.001     Document Type: Review

References (77)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
2. WHO Media Centre. Fact Sheet No. 297. Cancer. Available at: www.who.int/mediacentre/factsheets/fs297/en/ Accessed Oct. 2013.
3. Ashworth TR. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Aus Med J 1869;14:146-7.
4. Talasaz AH, Powell AA, Huber DE, et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc Natl Acad Sci U S A 2009;106:3970-5.
5. Bray F, Møller B. Predicting the future burden of cancer. Nat Rev Cancer 2006;6:63-74.
6. Danila DC, Fleisher M, Scher HI. Circulating tumor cells as biomarkers in prostate cancer. Clin Cancer Res 2011;17:3903-12.
7. Jain PK, El-Sayed IH, El-Sayed MA. Au nanoparticles target cancer. Nano Today 2007;2:18-29.
8. Budd GT. Let me do more than count the ways: what circulating tumor cells can tell us about the biology of cancer. Mol Pharm 2009;6:1307-10.
9. Bardhan R, Lal S, Joshi A, et al. Theranostic nanoshells: from probe design to imaging and treatment of cancer. Acc Chem Res 2011;44:936-46.
10. Eck W, Craig G, Sigdel A, et al. PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue. ACS Nano 2008;2:2263-72.
11. El-Sayed MA. Some interesting properties of metals confined in time and nanometer space of different shapes. Acc Chem Res 2001;34:257-64.
12. Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell 2006;127:679-95.
13. Adams AA, Okagbare PI, Feng J, et al. Highly efficient circulating tumor cell isolation from whole blood and labelfree enumeration using polymer-based microfluidics with an integrated conductivity sensor. J Am Chem Soc 2008;130:8633-41.
14. Nagrath S, Sequist LV, Maheswaran S, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007;450:1235-9.
15. Fan Z, Shelton M, Singh AK, et al. Multifunctional plasmonic shellemagnetic core nanoparticles for targeted diagnostics, isolation, and photothermal destruction of tumor cells. ACS Nano 2012;6:1065-73.
16. Fan Z, Senapati D, Singh AK, et al. Theranostic magnetic coreeplasmonic shell star shape nanoparticle for the isolation of targeted rare tumor cells from whole blood, fluorescence imaging, and photothermal destruction of cancer. Mol Pharm 2012;10:857-66.
17. Peleg G, Lewis A, Linial M, et al. Nonlinear optical measurement of membrane potential around single molecules at selected cellular sites. Proc Natl Acad Sci U S A 1999;96:6700-4.
18. Famulok M, Hartig JS, Mayer G. Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy. Chem Rev 2007;107:3715-43.
19. Laurent S, Forge D, Port M, et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008;108:2064-110.
20. Tassa C, Shaw SY, Weissleder R. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc Chem Res 2011;44:842-52.
21. Hyun KA, Lee TY, Jung HI. Negative enrichment of circulating tumor cells using a geometrically activated surface interaction chip. Anal Chem 2013;85:4439-45.
22. Wang J, Tian S, Petros RA, et al. The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies. J Am Chem Soc 2010;132:11306-13.
23. Park JH, von Maltzahn G, Ong LL, et al. Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery. Adv Mater 2010;22:880-5.
24. von Maltzahn G, Centrone A, Park JH, et al. SERS-coded gold nanorods as a multifunctional platform for densely multiplexed near-infrared imaging and photothermal heating. Adv Mater 2009;21:3175-80.
25. Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Clin Pharmacokinet 2003;42:419-36.
26. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4:145-60.
27. Lal S, Clare SE, Halas NJ. Nanoshell-enabled photothermal cancer therapy: impending clinical impact. Acc Chem Res 2008;41:1842-51.
28. Baker I, Zeng Q, Li W, et al. Heat deposition in iron oxide and iron nanoparticles for localized hyperthermia. J Appl Phys 2006;99. 08H106-08H106-3.
29. Yang W, Ahmed M, Elian M, et al. Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model? Radiology 2010;257:685-96.
30. Samia ACS, Chen X, Burda C. Semiconductor quantum dots for photodynamic therapy. J AmChem Soc 2003;125:15736-7.
31. Poon Z, Chen S, Engler AC, et al. Ligand-clustered "patchy" nanoparticles for modulated cellular uptake and in vivo tumor targeting. Angew Chem Int Ed Engl 2010;49:7266-70.
32. Gupta PB, Onder TT, Jiang G, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009;138:645-59.
33. Timko BP, Dvir T, Kohane DS. Remotely triggerable drug delivery systems. Adv Mater 2010;22:4925-43.
34. Burks SR, Ziadloo A, Hancock HA, et al. Investigation of cellular and molecular responses to pulsed focused ultrasound in a mouse model. PLoS ONE 2011;6:e24730.
35. Wu G, Mikhailovsky A, Khant HA, et al. Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells. J Am Chem Soc 2008;130:8175-7.
36. Derfus AM, von Maltzahn G, Harris TJ, et al. Remotely triggered release from magnetic nanoparticles. Adv Mater 2007;19:3932-6.
37. Chen F, Hong H, Zhang Y, et al. In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles. ACS Nano 2013;7:9027-39.
38. Pitsillides CM, Joe EK, Wei X, et al. Selective cell targeting with light-absorbing microparticles and nanoparticles. Biophys J 2003;84:4023-32.
39. Huang X, El-Sayed IH, Qian W, et al. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006;128:2115-20.
40. Huang X, Jain PK, El-Sayed IH, et al. Determination of the minimum temperature required for selective photothermal destruction of cancer cells with the use of immunotargeted gold nanoparticles. Photochem Photobiol 2006;82:412-7.
41. Lowery AR, Gobin AM, Day ES, et al. Immunonanoshells for targeted photothermal ablation of tumor cells. Int J Nanomedicine 2006;1:149-54.
42. Wang Y, Black KCL, Luehmann H, et al. Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment. ACS Nano 2013;7:2068-77.
43. Lu W, Singh AK, Khan SA, et al. Gold nano-popcorn-based targeted diagnosis, nanotherapy treatment, and in situ monitoring of photothermal therapy response of prostate cancer cells using surface-enhanced Raman spectroscopy. J Am Chem Soc 2010;132:18103-14.
44. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005;5:161-71.
45. Konan YN, Gurny R, Allémann E. State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B 2002;66:89-106.
46. Bakalova R, Ohba H, Zhelev Z, et al. Quantum dots as photosensitizers? Nat Biotechol 2004;22:1360-1.
47. Jang B, Park JY, Tung CH, et al. Gold nanorodephotosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo. ACS Nano 2011;5:1086-94.
48. Santra S, Kaittanis C, Santiesteban OJ, et al. Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy. J Am Chem Soc 2011;133:16680-8.
49. Noimark S, Dunnill CW, Kay CWM, et al. Incorporation of methylene blue and nanogold into polyvinyl chloride catheters; a new approach for light-activated disinfection of surfaces. J Mater Chem 2012;22:15388-96.
50. Zamboni WC, Torchilin V, Patri AK, et al. Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance. Clin Cancer Res 2012;18:3229-41.
51. Mieszawska AJ, Mulder WJM, Fayad ZA, et al. Multifunctional gold nanoparticles for diagnosis and therapy of disease. Mol Pharm 2013;10:831-47.
52. Ray PC. Size and shape dependent second order nonlinear optical properties of nanomaterials and their application in biological and chemical sensing. Chem Rev 2010;110:5332-65.
53. Kaittanis C, Santra S, Perez JM. Role of nanoparticle valency in the nondestructive magnetic-relaxation-mediated detection and magnetic isolation of cells in complex media. J Am Chem Soc 2009;131:1278091.
54. Lee GY, Qian WP, Wang L, et al. Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer. ACS Nano 2013;7:2078-89.
55. Wisner ER, Katzberg RW, Griffey SM, et al. Characterization of normal and cancerous lymph nodes on indirect computed tomography lymphographic studies after interstitial injection of iodinated nanoparticles. Acad Radiol 1996;3(Suppl. 2):S257-60.
56. Davis ME, Zuckerman JE, Choi CHJ, et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010;464:1067-70.
57. Louie A. Multimodality imaging probes: design and challenges. Chem Rev 2010;110:3146-95.
58. Mulvey JJ, Villa CH, McDevitt MR, et al. Self-assembly of carbon nanotubes and antibodies on tumours for targeted amplified delivery. Nat Nano 2013;8:763-71.
59. Sardana G, Jung K, Stephan C, et al. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers. J Proteome Res 2008;7:3329-38.
60. Usacheva MN, Teichert MC, Biel MA. The role of the methylene blue and toluidine blue monomers and dimers in the photoinactivation of bacteria. J Photochem Photobiol B 2003;71:87-98.
61. Tang W, Xu H, Park EJ, et al. Encapsulation of methylene blue in polyacrylamide nanoparticle platforms protects its photodynamic effectiveness. Biochem Biophys Res Commun 2008;369:579-83.
62. Lovell JF, Liu TW, Chen J, et al. Activatable photosensitizers for imaging and therapy. Chem Rev 2010;110:2839-57.
63. Cabral H, Nishiyama N, Kataoka K. Supramolecular nanodevices: from design validation to theranostic nanomedicine. Acc Chem Res 2011;44:999-1008.
64. Saha K, Agasti SS, Kim C, et al. Gold nanoparticles in chemical and biological sensing. Chem Rev 2012;112:2739-79.
65. Schuller JA, Barnard ES, Cai W, et al. Plasmonics for extreme light concentration and manipulation. Nat Mater 2010;9:193-204.
66. Wax A, Sokolov K. Molecular imaging and darkfield microspectroscopy of live cells using gold plasmonic nanoparticles. Laser Photonics Rev 2009;3:146-58.
67. Jin Y, Jia C, Huang SW, et al. Multifunctional nanoparticles as coupled contrast agents. Nat Commun 2010;1:41.
68. Hu X, Wei CW, Xia J, et al. Trapping and photoacoustic detection of CTCs at the Single Cell per milliliter level with magneto-optical coupled nanoparticles. Small 2013;9:2046-52.
69. Wang Y, Xu J, Wang Y, et al. Emerging chirality in nanoscience. Chem Soc Rev 2013;42:2930-62.
70. He J, Wei Z, Wang L, et al. Hydrodynamically driven selfassembly of giant vesicles of metal nanoparticles for remotecontrolled release. Angew Chem Int Ed Engl 2013;52:2463-8.
71. Lin J, Wang S, Huang P, et al. Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imagingguided photothermal/photodynamic therapy. ACS Nano 2013;7:5320-9.
72. Dreaden EC, Mackey MA, Huang X, et al. Beating cancer in multiple ways using nanogold. Chem Soc Rev 2011;40:3391-404.
73. Wang Y, Wang K, Zhao J, et al. Multifunctional mesoporous silica-coated graphene nanosheet used for chemophotothermal synergistic targeted therapy of glioma. J Am Chem Soc 2013;135:4799-804.
74. Singh AK, Khan SA, Fan Z, et al. Development of a long-range surface-enhanced Raman spectroscopy ruler. J AmChem Soc 2012;134:8662-9.
75. Wang E, Desai MS, Lee SW. Light-controlled graphene-elastin composite hydrogel actuators. Nano Letters 2013;13:2826-30.
76. Yuan H, Fales AM, Vo-Dinh T. TAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance. J Am Chem Soc 2012;134:11358-61.
77. Beqa L, Fan Z, Singh AK, et al. Gold nano-popcorn attached SWCNT hybrid nanomaterial for targeted diagnosis and photothermal therapy of human breast cancer cells. ACS Appl Mater Interfaces 2011;3:3316-24.